Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
Resource Type
Article
Authors
Yang, James Chih-Hsin ; Camidge, D. Ross ; Yang, Cheng-Ta ; Zhou, Jianying ; Guo, Renhua ; Chiu, Chao-Hua ; Chang, Gee-Chen ; Shiah, Her-Shyong ; Chen, Yuan ; Wang, Chin-Chou ; Berz, David ; Su, Wu-Chou ; Yang, Nong ; Wang, Ziping ; Fang, Jian ; Chen, Jianhua ; Nikolinakos, Petros ; Lu, You ; Pan, Hongming ; Maniam, Ajit ; Bazhenova, Lyudmila ; Shirai, Keisuke ; Jahanzeb, Mohammad ; Willis, Maurice ; Masood, Nehal ; Chowhan, Naveed ; Hsia, Te-Chun ; Jian, Hong ; Lu, Shun
Source
In Journal of Thoracic Oncology December 2020 15(12):1907-1918
Subject
Language
ISSN
1556-0864